Skip to main content
Educational comparison - not medical advice. This page compares two compounds for informational purposes. Neither is recommended as treatment. Any protocol decision is a conversation with your licensed healthcare provider.
Home/Peptides/BPC-157 vs TB-500
HEAD-TO-HEAD COMPARISON

BPC-157 vs TB-500

Users researching soft-tissue injury protocols, post-surgical recovery, or chronic tendinopathy.

QUICK ANSWER

BPC-157 drives local tissue repair (angiogenesis, gut healing) with a short half-life requiring daily dosing. TB-500 drives systemic cell migration with a ~2-day half-life requiring only 2× weekly. Key specs: BPC-157 (Healing, 30–60 minutes (systemic), with extended local tissue half-life, Subcutaneous or intramuscular) vs TB-500 (Healing, ~hours systemic; localized effects persist longer, Subcutaneous or intramuscular).

OPTION A
BPC-157
Body Protection Compound-157
Synthetic 15-amino-acid peptide derived from human gastric juice, studied for tissue repair and gut healing.
Full profile →
OPTION B
TB-500
Thymosin Beta-4 (TB-500)
Systemic cell-migration and tissue-repair peptide, most commonly stacked with BPC-157 for the "Wolverine" recovery protocol.
Full profile →
THE CORE DIFFERENCE

BPC-157 drives local tissue repair (angiogenesis, gut healing) with a short half-life requiring daily dosing. TB-500 drives systemic cell migration with a ~2-day half-life requiring only 2× weekly. Community users stack them ("Wolverine Stack") because the mechanisms are complementary - BPC-157 for local injury sites, TB-500 for the broader cellular migration signal.

BEST FOR
Recover Faster →Skin & Aesthetics →Gut Health →Immunity →
Each protocol guide pairs the relevant compounds with the supplement stack that supports them and the biomarkers that show whether it’s working.
FEATURE COMPARISON
BPC-157
TB-500
Full name
Body Protection Compound-157
Thymosin Beta-4 (TB-500)
Category
Healing
Healing
FDA status
Not FDA-approved. Available via 503A compounding pharmacies (Category 1, post-2026 reclassification).
Not FDA-approved. Category 1 under the 2026 peptide reclassification.
Half-life
30–60 minutes (systemic), with extended local tissue half-life
~hours systemic; localized effects persist longer
Typical dosing
200–500 mcg/day, subcutaneous injection near injury site or systemic
2–2.5 mg loading 2× weekly for 4–6 weeks, then 1–2 mg weekly maintenance
Route
Subcutaneous or intramuscular
Subcutaneous or intramuscular
Classification
Synthetic pentadecapeptide
Synthetic 17-amino-acid actin-binding peptide
BIOMARKERS COMMONLY TRACKED
On BPC-157
  • • hs-CRP (inflammation)
  • • CBC with differential
  • • Ferritin
  • • IGF-1 (when stacked)
On TB-500
  • • hs-CRP
  • • CBC with differential
  • • Ferritin
  • • Serum copper (if stacked with GHK-Cu)
CALCULATOR
BPC-157 reconstitution →
CALCULATOR
TB-500 reconstitution →
CONDITIONS USERS RESEARCH THESE FOR
Informational only - neither compound is presented as a treatment for any condition. These are contexts in which users research these compounds and discuss them with their licensed provider.
INFLAMMATION
Chronic Low-Grade Inflammation
The persistent low-level inflammatory pattern linked to cardiovascular, metabolic, and cognitive disease - trackable via specific markers.
RECOVERY
Poor Recovery / Overtraining
The pattern users see when training load exceeds recovery capacity - trackable via HRV, RHR, and specific biomarkers.
RELATED COMPARISONS
GHK-Cu vs BPC-157
FREQUENTLY ASKED QUESTIONS

What is the difference between BPC-157 and TB-500?

BPC-157 drives local tissue repair (angiogenesis, gut healing) with a short half-life requiring daily dosing. TB-500 drives systemic cell migration with a ~2-day half-life requiring only 2× weekly. Community users stack them ("Wolverine Stack") because the mechanisms are complementary - BPC-157 for local injury sites, TB-500 for the broader cellular migration signal.

Who typically researches BPC-157 vs TB-500?

Users researching soft-tissue injury protocols, post-surgical recovery, or chronic tendinopathy. BPC-157 (Healing, 30–60 minutes (systemic), with extended local tissue half-life, Subcutaneous or intramuscular) and TB-500 (Healing, ~hours systemic; localized effects persist longer, Subcutaneous or intramuscular) differ in mechanism and dosing cadence - the right choice depends on protocol goals, biomarker baseline, and provider guidance. MyProtocolStack lets you log doses and lab values for both side-by-side if you're cycling between them.

What blood markers do users track on BPC-157 or TB-500?

Biomarkers commonly tracked across BPC-157 and TB-500 protocols include hs-CRP (inflammation), CBC with differential, Ferritin, IGF-1 (when stacked), hs-CRP, Serum copper (if stacked with GHK-Cu). Establishing a baseline before starting and re-drawing at consistent intervals lets you measure each compound's effect against your own reference point - generic lab ranges are less informative than your personal trend over time. MyProtocolStack tracks these biomarkers in the context of whichever compound you're currently running.

Whichever you're tracking, we built the dashboard for it.

Log doses, upload labs, watch the biomarkers trend. StackAI reads your panel in context of what you're actually running.

Start tracking free →

Informational comparison only - not medical advice. Research-stage compounds discussed are not FDA-approved unless specifically noted. Any protocol decision should be made with a licensed healthcare provider.